Literature DB >> 1375794

Expression of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and in the placenta.

D P Wang1, S Fujii, I Konishi, Y Nanbu, T Iwai, H Nonogaki, T Mori.   

Abstract

The c-erbB-2 (HER-2/neu) protein is a membrane glycoprotein growth factor receptor that has molecular homology with the epidermal growth factor receptor (EGFR). To investigate the relationship between the expression of c-erbB-2 protein and EGFR in the tissues of the human female genital tract and in the placenta, we examined the immunohistochemical reactivity of monoclonal antibodies against both of these proteins. In the müllerian-derived genital tract, epithelial cells of the fallopian tube, endometrium, and endocervix showed reactivity for c-erbB-2 protein, whereas reactivity for EGFR was distributed mainly in the stromal cells throughout the menstrual cycle and during pregnancy. In addition, the staining intensity for EGFR in the endometrial stroma increased with its decidualization. In the exocervical squamous epithelium, basal cells were c-erbB-2 protein-negative and EGFR-positive, but the more differentiated squamous cells of the intermediate layer were c-erbB-2 protein-positive and EGFR-negative. In the placental tissues, cytotrophoblasts and syncytiotrophoblasts of the chorionic villi were c-erbB-2 protein-negative and EGFR-positive. In contrast, intermediate trophoblasts in the extravillous space were c-erbB-2 protein-positive and EGFR-negative. Thus, there is an inverse relationship between the expression of c-erbB-2 protein and EGFR in the tissues of the female genital tract and in the placenta. This suggests that there may be a regulatory mechanism(s) for the expression of both proteins that is associated with the differentiation and/or function of cells in the female genital tract and the placenta.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375794     DOI: 10.1007/bf01600509

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  29 in total

1.  c-erbB-2 oncogene expression in ovarian cancer.

Authors:  J S Haldane; V Hird; C M Hughes; W J Gullick
Journal:  J Pathol       Date:  1990-11       Impact factor: 7.996

2.  Regulation of human endometrial and decidual cell functions--role of epidermal growth factor in the decidualization.

Authors:  T Yamamoto; M Nishiyama; K Yanoh; Y Naka; A Naka; Y Sugiyama
Journal:  Prog Clin Biol Res       Date:  1989

3.  Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.

Authors:  S Fukushige; K Matsubara; M Yoshida; M Sasaki; T Suzuki; K Semba; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

4.  Expression of the c-erbB-2 protein in normal and transformed cells.

Authors:  W J Gullick; M S Berger; P L Bennett; J B Rothbard; M D Waterfield
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

5.  An immunohistological comparison of the secretory capacity of villous and extravillous trophoblast in the human placenta.

Authors:  S Gosseye; H Fox
Journal:  Placenta       Date:  1984 Jul-Aug       Impact factor: 3.481

6.  Immunohistochemical localization of epidermal growth factor receptor and myc oncogene product in human placenta: implication for trophoblast proliferation and differentiation.

Authors:  T Maruo; M Mochizuki
Journal:  Am J Obstet Gynecol       Date:  1987-03       Impact factor: 8.661

7.  The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen.

Authors:  A L Schechter; D F Stern; L Vaidyanathan; S J Decker; J A Drebin; M I Greene; R A Weinberg
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

8.  Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Authors:  A Berchuck; A Kamel; R Whitaker; B Kerns; G Olt; R Kinney; J T Soper; R Dodge; D L Clarke-Pearson; P Marks
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

9.  Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

Authors:  M F Press; C Cordon-Cardo; D J Slamon
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

10.  Cyclic changes in epidermal growth factor receptor in human endometrium during menstrual cycle.

Authors:  Y Taketani; M Mizuno
Journal:  Endocrinol Jpn       Date:  1988-02
View more
  8 in total

1.  HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels.

Authors:  Thomas Vauvert F Hviid; Sine Hylenius; Christina Rørbye; Lone G Nielsen
Journal:  Immunogenetics       Date:  2003-04-24       Impact factor: 2.846

2.  Growth factor mRNA expression in normal colorectal mucosa and in uninvolved mucosa from ulcerative colitis patients.

Authors:  A Chowdhury; R Fukuda; S Fukumoto
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

3.  The profile of the epidermal growth factor system in rat endometrium during postpartum involution period.

Authors:  Emel Alan; Narin Liman; Hakan Sağsöz
Journal:  Vet Res Commun       Date:  2015-03-11       Impact factor: 2.459

4.  Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle.

Authors:  A Gompel; A Martin; P Simon; D Schoevaert; G Plu-Bureau; D Hugol; J Audouin; E Leygue; J B Truc; P Poitout
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 5.  EGFR/HER-targeted therapeutics in ovarian cancer.

Authors:  Jason A Wilken; Tayf Badri; Sarah Cross; Rhoda Raji; Alessandro D Santin; Peter Schwartz; Adam J Branscum; Andre T Baron; Adam I Sakhitab; Nita J Maihle
Journal:  Future Med Chem       Date:  2012-03       Impact factor: 3.808

6.  Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma.

Authors:  C Uzan; E Darai; A Valent; O Graesslin; A Cortez; R Rouzier; P Vielh
Journal:  Virchows Arch       Date:  2009-03-18       Impact factor: 4.064

7.  Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.

Authors:  D P Wang; I Konishi; M Koshiyama; Y Nanbu; T Iwai; H Nonogaki; T Mori; S Fujii
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

8.  Decreased expression of Ras GTPase activating protein in human trophoblastic tumors.

Authors:  M Ståhle-Bäckdhal; M Inoue; J Zedenius; B Sandstedt; L DeMarco; F Flam; C Silfverswärd; J Andrade; E Friedman
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.